FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity
2003/06/01 by Olivier Barbier, Inès Pineda‐Torra, Ines Pineda Torra +11 · 201 citations
Biochemistry, Genetics and Molecular Biology · Chemistry · Medicine · Pharmacology, Toxicology and Pharmaceutics · #Bile acid #Biochemistry #Biology #Chemistry #Chenodeoxycholic acid #Chromatin immunoprecipitation #Drug Transport and Resistance Mechanisms #Farnesoid X receptor #G protein-coupled bile acid receptor #Gene #Gene expression #Nuclear receptor #Pharmacogenetics and Drug Metabolism #Promoter #Retinoid X receptor #Retinoids in leukemia and cellular processes #Small heterodimer partner #Transcription factor
paper · doi:10.1016/s0016-5085(03)00388-3
published in Gastroenterology 124(7), 1926-1940 (Elsevier BV)
openalex publication_date 2003/06/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01
Cited by
- Establishing Transcriptional Signatures to Differentiate PXR-, CAR-, and AhR-Mediated Regulation of Drug Metabolism and Transport Genes in Cryopreserved Human Hepatocytes
- Pharmaco-nutraceutical improvement of the response to obeticholic acid with omega-3 polyunsaturated fatty acids
- The Janus face of phase II drug-metabolizing enzymes in hypoxia: guardian of antioxidant defense or accomplice in metabolic disorders?
- REGULATION OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS IN INFLAMMATION
- Plasma Apolipoprotein C-III Levels, Triglycerides, and Coronary Artery Calcification in Type 2 Diabetics
- Role of Nuclear Receptors in the Adaptive Response to Bile Acids and Cholestasis: Pathogenetic and Therapeutic Considerations
- Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: a potential role for a negative farnesoid X receptor response element. [europepmc]
- New perspectives for the treatment of cholestasis: lessons from basic science applied clinically. [europepmc]
- Regulation of FXR transcriptional activity in health and disease: Emerging roles of FXR cofactors and post-translational modifications. [europepmc]
- A signature of balancing selection in the region upstream to the human UGT2B4 gene and implications for breast cancer risk. [europepmc]
- Farnesoid X receptor represses hepatic human APOA gene expression. [europepmc]
- FXR signaling in the enterohepatic system. [europepmc]
- Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective. [europepmc]
- Nuclear receptor control of enterohepatic circulation. [europepmc]
- Nutritional lipidomics: molecular metabolism, analytics, and diagnostics. [europepmc]
- FXR-induced secretion of FGF15/19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway. [europepmc]
- Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion. [europepmc]
- Nuclear bile acid signaling through the farnesoid X receptor. [europepmc]
- Fibrates and cholestasis. [europepmc]
- Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics. [europepmc]
- Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and Cancer. [europepmc]
- Nuclear Receptor Metabolism of Bile Acids and Xenobiotics: A Coordinated Detoxification System with Impact on Health and Diseases. [europepmc]
- Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer. [europepmc]
- Bile Acid Signaling in Neurodegenerative and Neurological Disorders. [europepmc]
- Potential role of drug metabolizing enzymes in chemotherapy-induced gastrointestinal toxicity and hepatotoxicity. [europepmc]
- Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease. [europepmc]
- Distinct Bile Acid Profiles in Patients With Chronic Hepatitis B Virus Infection Reveal Metabolic Interplay Between Host, Virus and Gut Microbiome. [europepmc]
- Enterohepatic and non-canonical roles of farnesoid X receptor in controlling lipid and glucose metabolism. [europepmc]
- The role of bile acids in carcinogenesis. [europepmc]
- PPARα: A potential therapeutic target of cholestasis. [europepmc]
- Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety-A Role for Bile Acids. [europepmc]